Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sangrose Laboratories is an Indian pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company is globally recognized as a leading producer of clofazimine, a critical medication used in the treatment of leprosy and multi-drug resistant tuberculosis. Operating from its WHO-GMP certified manufacturing facilities in Kerala, Sangrose provides high-quality affordable medicines to both domestic and international markets, including supplies to global health organizations. Their business model focuses on the chemical synthesis of niche APIs and the production of essential anti-infective formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sangrose Laboratories.